Keyword Analysis & Research: relypsa drug list
Keyword Research: People who searched relypsa drug list also searched
Search Results related to relypsa drug list on Search Engine
-
Relypsa, Inc. - MPR - Prescription & OTC Drug Info
https://www.empr.com/manufacture/relypsa-inc/
Please login or register first to view this content. Back to Top Resources
DA: 29 PA: 29 MOZ Rank: 61
-
After ZS Pharma buyout, Relypsa slated to be next on the hit list
https://www.fiercebiotech.com/biotech/after-zs-pharma-buyout-relypsa-slated-to-be-next-on-hit-list
As hype around new treatments for the blood disorder hyperkalemia continues unabated after AstraZeneca's $2.7 billion buyout of ZS Pharma last year, Relypsa, which recently gained the …
DA: 17 PA: 94 MOZ Rank: 38
-
Relypsa Announces FDA Approval of Supplemental New Drug
https://www.globenewswire.com/news-release/2018/05/08/1498379/0/en/Relypsa-Announces-FDA-Approval-of-Supplemental-New-Drug-Application-to-Enable-the-Usage-of-Veltassa-patiromer-With-or-Without-Food.html
These include renin angiotensin aldosterone system (RAAS) inhibitors such as angiotensin receptor blockers (ARBs), aldosterone antagonists (AAs) and angiotensin-converting-enzyme (ACE) inhibitors....
DA: 36 PA: 24 MOZ Rank: 64
-
FDA approves Relypsa's drug to treat high potassium levels
https://www.reuters.com/article/us-relypsa-fda-idUSKCN0SF2ZQ20151021
By Anjali Rao Koppala. 3 Min Read. (Reuters) - The U.S. Food and Drug Administration approved Relypsa Inc’s drug to treat potentially fatal levels of potassium in patients with chronic kidney ...
DA: 89 PA: 40 MOZ Rank: 3
-
Relypsa's Hyperkalemia Drug Veltassa Approved in the U.S.
https://www.nasdaq.com/articles/relypsas-hyperkalemia-drug-veltassa-approved-in-the-u.s.-2015-10-23
Relypsa, Inc. 's RLYP lead candidate, Veltassa gained approval in the U.S. for the treatment of hyperkalemia. Shares which should have been up with. …
DA: 77 PA: 89 MOZ Rank: 76
-
Products | Vifor Pharma
https://www.viforpharma.com/products
VML Technology - Redefining video to communicate and educate across the globe. WE CONTINUE HELPING PATIENTS LEAD BETTER, HEALTHIER LIVES. Vifor Pharma aims to be a leader in iron deficiency, nephrology and cardio-renal therapies. We strive to help patients with severe and chronic disease lead better, healthier lives.
DA: 77 PA: 85 MOZ Rank: 42
-
NDC Codes - National Drug Codes - Find-A-Code
https://www.findacode.com/ndc/labelers/Relypsa%2C_Inc.
Check-A-List™ Provider Documentation Guides™ (PDGs) SuperBill Builder™ education & training. Find-A-Code User Conference 2021; CEUs & Training; Coding Courses; ZygoteBody™ - Anatomy Viewer; Anatomy/Physiology Games; more topics. Facilities & Organizations - ACOs, Hospitals, etc. Payers - Medicare, Medicaid, BC/BS, Aetna, etc.
DA: 45 PA: 74 MOZ Rank: 46
-
Generic Veltassa Availability - Drugs.com
https://www.drugs.com/availability/generic-veltassa.html
There is currently no therapeutically equivalent version of Veltassa available in the United States. Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Veltassa. These medications may be counterfeit and potentially unsafe.
DA: 99 PA: 60 MOZ Rank: 46
-
VELTASSA (Vifor Pharma, Inc.): FDA Package Insert
https://medlibrary.org/lib/rx/meds/veltassa/
7 drug interactions In clinical studies, Veltassa decreased systemic exposure of some coadministered oral medications [see Clinical Pharmacology (12.3) ] . Binding of Veltassa to other oral medications could cause decreased gastrointestinal absorption and loss of efficacy when taken close to the time Veltassa is administered.
DA: 98 PA: 62 MOZ Rank: 68
-
Home | Vifor Pharma
https://www.viforpharma.com/us
Vifor Pharma aims to be the global leader in iron deficiency and nephrology. We strive to help patients with severe and chronic disease lead better, healthier lives. OUR THERAPEUTIC AREAS We are a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann ...
DA: 15 PA: 42 MOZ Rank: 77
